Arena Pharmaceuticals Inc.
Rank 9
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
$81.0200
USD
-0.49%
Market cap
$4,036,834,625
Total volume
$34,893,099
Shares outstanding
49,825,162
Rank 9
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ARNA |
$34,893,099
|
100% |
$81.0200
|
Chart